Welcome to our dedicated page for Protect Pharmace news (Ticker: PRTT), a resource for investors and traders seeking the latest updates and insights on Protect Pharmace stock.
Protect Pharms Corp (PRTT) is a pharmaceutical company specializing in the development and distribution of innovative medicines for various health conditions. They prioritize research and development to create cutting-edge products that improve patient outcomes and quality of life. With a strong focus on regulatory compliance and quality assurance, Protect Pharms Corp has established itself as a trusted name in the industry. The company's financial stability and strategic partnerships position them for continued growth and success in the competitive pharmaceutical market.
Protect Pharmaceutical Corp. (OTC: PRTT) has announced that its previously reported merger with KARINCA Logistics will not proceed. The announcement made on August 28, 2024, regarding the merger should be disregarded. An unforeseen business issue emerged during the final due diligence process at closing, leading to the termination of the deal. No shares or monetary exchange took place between the parties. The company's management states that current plans do not involve KARINCA Logistics, and they will continue to update shareholders on future progress. Additionally, Director George Athanasiadis has resigned from the board of directors.
Protect Pharmaceutical Corp. (OTC: PRTT) has finalized its merger with KARINCA Logistics, a move expected to significantly enhance the company's operations. The merger brings valuable assets including a large network, important routes, and expanded sales opportunities across Europe and Asia. To complete the deal, PRTT issued 1,000,000 additional Preferred Shares with 100:1 voting rights, avoiding common share dilution.
CEO Ozgur Ozcan emphasized that the company's priority is now to complete the PCAOB audit, file a FORM 10 registration statement, and resume SEC reporting in preparation for an exchange uplisting. The merger is anticipated to generate new revenue streams and profitability for PRTT in the current calendar year.
Protect Pharmaceutical Corp. (OTC: PRTT) has announced significant changes in its leadership and a pending merger with Karinca Logistics. Ozgur Ozcan has been appointed as the new CEO and Director, while George Athanasiadis joins as a Director. These appointments come alongside the resignations of Ali Yildiz as CEO and Tatiana Aleinikov as VP of Operations.
The company is in the final stages of merging with Karinca Logistics, a move expected to boost revenue and profitability. PRTT plans to provide shareholders with an update on the merger and pending audit within a week. The company also intends to file a Form 10 registration with the SEC to resume reporting standards and aims to uplist to an exchange. A company name change is also in the works to better reflect its current business focus.
Protect Pharmaceutical Corp. (OTC: PRTT) is nearing the completion of its PCAOB audit for fiscal year 2023, with only a few pending items in Turkey. The company plans to file a Form 10 and apply for an uplist upon audit completion. Additionally, the company plans a corporate name and symbol change to Atlantic Logistics. Protect Pharmaceutical is also finalizing a merger with Karinca Logistics, a major Turkish logistics company. This merger is expected to increase revenues by 2.5 times, surpassing $250 million, and significantly boost profitability. The merger will reintroduce profitable transit routes halted due to geopolitical issues and open new opportunities in Asia. This strategic move aims to expand the company's reach, storage, and transit capacities, positioning it as a global logistics leader.
FAQ
What is the current stock price of Protect Pharmace (PRTT)?
What is the market cap of Protect Pharmace (PRTT)?
What is Protect Pharms Corp's core business?
What sets Protect Pharms Corp apart from other pharmaceutical companies?
How does Protect Pharms Corp ensure quality and compliance in its products?
What is Protect Pharms Corp's approach to research and development?
What is Protect Pharms Corp's strategy for growth and success?
How can I contact Protect Pharms Corp for more information?
Does Protect Pharms Corp have a strong reputation in the industry?
What are Protect Pharms Corp's long-term goals?
How does Protect Pharms Corp contribute to patient care?
What future projects is Protect Pharms Corp working on?
What is Protect Pharms Corp's customer service like?
How does Protect Pharms Corp stay competitive in the pharmaceutical market?
What are some recent achievements of Protect Pharms Corp?
What opportunities does Protect Pharms Corp offer for investors?
How does Protect Pharms Corp contribute to community health and well-being?
What values guide Protect Pharms Corp in its operations and decision-making?
What impact does Protect Pharms Corp have on the healthcare industry?
What role does Protect Pharms Corp play in the global pharmaceutical market?
How does Protect Pharms Corp prioritize patient safety and well-being?
What opportunities exist for partnership or collaboration with Protect Pharms Corp?
What is the vision and mission of Protect Pharms Corp?
How does Protect Pharms Corp support healthcare providers and professionals?
What sets Protect Pharms Corp's products apart in the market?
How does Protect Pharms Corp promote sustainability and environmental responsibility?
What educational initiatives or programs does Protect Pharms Corp support?
What regulatory standards and guidelines does Protect Pharms Corp adhere to?
How does Protect Pharms Corp foster a culture of innovation and creativity?
Does Protect Pharms Corp have a global presence?
